Table 5:
Previous studies on the prevalence of novel autoantibodies in dry eye patients with or without Sjogren syndrome
| Sjogren Syndrome | Non-Sjogren Syndrome | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Study | N | Any | SP-1 | PSP | CA-6 | N | Any | SP-1 | PSP | CA-6 |
| Current Study | 81 | 43% | 21% | 35% | 15% | 129 | 36% | 12% | 21% | 20% |
| Karakus et al (J Immunol Res 2019) | 11 primary SS | 73% | 27% | 54% | 27% | 97 | 38% | 13% | 10% | 22% |
| 7 secondary SS | 14% | 14% | 0 | 0 | ||||||
| Bunya DREAM (Cornea 2018) | 52 | 46% | 33% | 14% | 21% | 352 | 31% | 19% | 9% | 15% |
| Karakus et al (Cornea 2018) | 46 | 13% | 11% | 52% | 14% | 14% | 43% | |||
| Everett et al (BMC Ophthalmol 2017) | 62 | 60% | ||||||||
| Matossian (Clin Ophthalmol 2016) | 41 | 21% | ||||||||
| Shen et al (Clin Immunol 2014) | 123 | 52% | ||||||||
| Shen et al (Clin Immunol 2012) | 13 | 54% | 18% | 54% | ||||||